About 3,293 results

ALLMedicine™ Sickle Cell Anemia Center

Research & Reviews  1,019 results

Improvement of Hemolytic Anemia with GBT1118 is Reno-protective in Transgenic Sickle Mice.
Blood Advances; Ren G, Setty S et. al.

Jun 28th, 2022 - Hemolysis and hemoglobinuria are risk factors for kidney disease and its progression in sickle cell anemia (SCA). Voxelotor is a small molecule allosteric hemoglobin modulator that reduces hemolysis in SCA. We administered GBT1118, an analogue of ...

Transcranial doppler as screening method for sickling crises in children with sickle ce...
https://doi.org/10.1186/s12887-022-03429-5 10.1016/s0140-6736(17)30193-9 10.1056/NEJMra1510865 10.1073/pnas.1505665112 10.1016/j.neulet.2019.134471 10.1007/s11739-019-02160-x 10.3410/f.726014408.793549711 10.1517/14712598.6.11.1087 10.1056/nejm199807023390102 10.1016/j.jpeds.2010.03.007 10.1590/s1516-31802011000300003 10.1371/journal.pone.0229959 10.3390/jcm9010044 10.1002/pbc.28172 10.1111/bjh.17620 10.1080/03630269.2020.1843483 10.1016/j.chest.2015.12.016 10.1177/003335491312800206 10.2147/jpr.s185582 10.1146/annurev-pathmechdis-012418-012838 10.1001/jama.2010.378 10.7326/0003-4819-148-2-200801150-00004 10.1016/j.bjhh.2015.03.013 10.1046/j.1365-2141.2003.04594.x 10.1101/cshperspect.a011783 10.1590/s0004-282x2008000300015 10.1172/JCI89741 10.1002/jcu.22663 10.1590/0004-282x20160175 10.1002/ajh.24198 10.1002/pbc.25529 10.1016/j.jstrokecerebrovasdis.2017.09.020 10.1016/s0140-6736(11)60355-3 10.1016/j.jstrokecerebrovasdis.2018.05.042 10.3389/fped.2020.00038 10.1067/mpd.2001.119593 10.1177/000992289503401015 10.1177/0009922815614351 10.5581/1516-8484.20120078 10.1186/1824-7288-35-15 10.1016/j.pediatrneurol.2021.08.010
BMC Pediatrics; Modolo GP, Luvizutto GJ et. al.

Jun 28th, 2022 - Sickle cell anemia (SCA) is the leading cause of childhood stroke. We aimed to evaluate whether altered cerebral flow velocities, as measured by transcranial Doppler (TCD), are associated with vaso-occlusive complications in addition to stroke in ...

Stroke propensity in the Th3+/ mouse model of β-thalassemia intermedia.
Neurobiology of Disease; Sun YY, Yao HW et. al.

Jun 27th, 2022 - β-thalassemia is associated with multiple hematological and cerebrovascular symptoms linked to a hypercoagulable state that has not been fully replicated in animal models for the development of stroke treatments. Herein we compared the physiologic...

Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia

Jun 24th, 2022 - Sickle cell anemia is an autosomal recessive disorder and the most common genetic disease affecting African-Americans. Approximately 0.15% of African-Americans are homozygous for sickle cell disease, and 8% have sickle cell trait. Acute pain crisi...

Effects of pregnancy on cardiac structure and function in women with sickle cell anemia...
The Journal of Maternal-fetal & Neonatal Medicine : the O... Aliyu Z, Kushimo OA et. al.

Jun 21st, 2022 - Sickle cell anemia is the commonest hemoglobinopathy in pregnant Nigerian women, and cardiac manifestations are a significant feature of the disease especially in pregnancy. Pregnant women with sickle cell anemia are at high risk of morbidity and ...

see more →

Guidelines  1 results

Cardiovascular function and treatment in β-thalassemia major: a consensus statement fro...
Circulation Pennell DJ, Udelson JE et. al.

Jun 19th, 2013 - This aim of this statement is to report an expert consensus on the diagnosis and treatment of cardiac dysfunction in β-thalassemia major (TM). This consensus statement does not cover other hemoglobinopathies, including thalassemia intermedia and s...

see more →

Drugs  3 results see all →

Clinicaltrials.gov  160 results

Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia

Jun 24th, 2022 - Sickle cell anemia is an autosomal recessive disorder and the most common genetic disease affecting African-Americans. Approximately 0.15% of African-Americans are homozygous for sickle cell disease, and 8% have sickle cell trait. Acute pain crisi...

A Voxelotor for Sickle Cell Anemia Patients at Highest Risk for Progression of Chronic Kidney Disease

Jun 21st, 2022 - This study is a single center, prospective exploratory pilot study of Sickle Cell Anemia (SCA) participants, age ≥18 years, with SCA. The study will enroll patients with early stages of sickle cell nephropathy (Chronic Kidney Disease (CKD) stage 1...

The Montreal Cognitive Assessment.Test in Adults With Sickle Cell Disease

May 26th, 2022 - Sickle cell anemia is a monogenic disease affecting the beta-chain of hemoglobin. Cognitive impairment is more prevalent in patients with sickle cell disease than in matched unaffected individuals. Validated tests to screen for cognitive impairmen...

The Predictive Capacity of Machine Learning Models for Progressive Kidney Disease in Individuals With Sickle Cell Anemia

May 24th, 2022 - Sickle cell disease (SCD) is characterized by a vasculopathy affecting multiple end organs, with complications including ischemic stroke, pulmonary hypertension, and chronic kidney disease (CKD). Albuminuria, an early measure of glomerular injury ...

A Trial to Assess the Effect of Transfusion Strategies on Fatigability Levels After Hospital Discharge

May 19th, 2022 - The design of this proposed study is a randomized controlled trial of hospitalized adult general medicine patients with anemia at the University of Chicago (UC). Patients will be randomized to receive transfusion at either a hemoglobin (Hb)<9g/dL ...

see more →

News  126 results

Are We Any Closer to Intestinal Gene Therapy in Crohn's Disease?

May 24th, 2022 - This transcript has been edited for clarity. Peter Higgins, MD, PhD: Hello. I'm Dr Peter Higgins, and welcome to Medscape's InDiscussion series on Crohn's disease. Today we'll be discussing gene therapy trials. Given the recent successes with sick...

Longer Hydroxyurea Tied to Improved Sickle-Cell Heart Issues

Sep 16th, 2021 - Prolonged treatment with hydroxyurea may improve -- and possibly even reverse -- cardiac complications in pediatric patients with sickle cell anemia, a retrospective study found. Those on hydroxyurea for less than 1 year had a significantly greate...

Sickle Cell Disease Tied to COVID-19 Mortality, Hospitalizations

Jul 21st, 2021 - Sickle cell disease (SCD) was associated with a significantly increased risk of COVID-19-related hospitalization and death in adults, U.K. researchers found. Their cohort study showed that having SCD quadrupled a person's risk for COVID-19-related...

Transfusion Dependence in Adult Sickle Cell Anemia

Apr 2nd, 2021 - Transfusion is 1 of 2 disease-modifying therapies for adults with sickle cell anemia, the other being hydroxyurea, explains Morey Blinder, MD. There are several indications for transfusion in patients with sickle cell disease, with the best studie...

Emotions, worse attention linked to pain-related health care use in SCD
Neil Osterweil

Dec 9th, 2020 - The cognitive and emotional status of children with sickle cell disease (SCD) appears to have a significant effect on how they cope with pain and use health care resources, investigators have found. Results of a retrospective study of 112 children.

see more →

Patient Education  8 results see all →